What the MFI Reveals About Medican Enterprises Inc

New Post Public Reply Private Reply Replies (0) Message Board
BionicBen
999
What the MFI Reveals About Medican Enterprises Inc (MDCN)
https://finnewsweek.com/what-the-mfi-reveals-...cn/634606/

Medican Enterprises Inc (MDCN) shares have sparked the interest of some chartists as the Money Flow Index has climbed above 60, potentially heading for key 70 levels. The Money Flow Index is an indicator that utilizes the volume and volatility of an asset to determine the buying or selling pressure of an asset. The indicator was developed by Avrum Soudack and Gene Quong as a volume-weighted variation of the RSI.
The Money Flow Index is calibrated from 0 to 100, and creates a money flow ratio (Positive Money Flow to Negative Money Flow) over a time period. This money flow ratio is what is pushed into an RSI formula to create a momentum indicator. Being a momentum indicator, the Money Flow Index (MFI) is capable evaluating overbought and oversold market conditions, using values of 70-80 and above for overbought conditions and 20 and below for oversold situations.

Investors might be interested in taking a closer look at additional stock technical levels. After a recent check, Medican Enterprises Inc (MDCN) has a 14-day ATR of 0.00. The average true range indicator was created by J. Welles Wilder in order to measure volatility. The ATR may help traders to determine the strength of a breakout or reversal in price. It is important to mention that the ATR was not designed to calculate price direction or to predict future prices.

Currently, the 14-day ADX for Medican Enterprises Inc (MDCN) is sitting at 72.90. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend. A value of 25-50 would support a strong trend. A value of 50-75 would identify a very strong trend, and a value of 75-100 would lead to an extremely strong trend. ADX is used to gauge trend strength but not trend direction. Traders often add the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI) to identify the direction of a trend.

Checking in on some other technical levels, the 14-day RSI is currently at 46.63, the 7-day stands at 42.38, and the 3-day is sitting at 30.77. Many investors look to the Relative Strength Index (RSI) reading of a particular stock to help identify overbought/oversold conditions. The RSI was developed by J. Welles Wilder in the late 1970’s. Wilder laid out the foundation for future technical analysts to further investigate the RSI and its relationship to underlying price movements. Since its inception, RSI has remained very popular with traders and investors. Other technical analysts have built upon the work of Wilder. The 14-day RSI is still a widely popular choice among technical stock analysts.

Investors may be watching other technical indicators such as the Williams Percent Range or Williams %R. The Williams %R is a momentum indicator that helps measure oversold and overbought levels. This indicator compares the closing price of a stock in relation to the highs and lows over a certain time period. A common look back period is 14 days. Medican Enterprises Inc (MDCN)’s Williams %R presently stands at -100.00. The Williams %R oscillates in a range from 0 to -100. A reading between 0 and -20 would indicate an overbought situation. A reading from -80 to -100 would indicate an oversold situation.

Taking a closer look from a technical standpoint, Medican Enterprises Inc (MDCN) presently has a 14-day Commodity Channel Index (CCI) of 31.11. Typically, the CCI oscillates above and below a zero line. Normal oscillations tend to stay in the range of -100 to +100. A CCI reading of +100 may represent overbought conditions, while readings near -100 may indicate oversold territory. Although the CCI indicator was developed for commodities, it has become a popular tool for equity evaluation as well.

Some recent web articles. Nice to see some dust kicking up. The twitter battle is pretty comical too. MDCN is just a matter of time until things are sorted out and a new venture begins.

Medican Enterprises Inc (MDCN) Stock Research Links

MDCN Board Company Profile Buy Rating Time & Sales News Filings Financials
Disclaimer:
There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator.
Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.
There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in all and any posts.
My posts are NOT investment advice. I am not paid to post.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 22

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 15

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 28

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 19

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 24

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 11

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 23

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Excitement Builds for the 2025 Special Olympics Winter Games

Updated Category News Views 612

The Opening Ceremony of the 2025 Special Olympics World Winter Games In a grand celebration last night, the lights illuminated the Inalpi Arena, marking the commencement of the 2025 Special Olympics World Winter Games in Turin. This event is poised to become the largest sports and humanitarian gathering of the year. With the lighting of the "Flame of Hope," over 1,500...

Continue Reading
Embracing Pet Ownership: Older Canadians Thrive with Pets

Updated Category News Views 173

Discover the Joy of Pet Ownership Among Older Canadians Pet ownership can transform lives, and for older Canadians, the companionship of a furry friend offers numerous emotional and physical benefits. According to a recent survey by Ipsos for HomeEquity Bank, it has become evident that many Canadians aged 55 and over understand the significant value of sharing their lives...

Continue Reading
Salus Scientific: A Solid Stand Against Industry Recalls Risk

Updated Category News Views 283

Reputation on the Line Nothing shakes the confidence of hospitals like a recall. You know how it is—one day, everything's rolling along fine, and then BAM, safety issues pop up like bad news at a family dinner. Take Salus Scientific, for instance. They’re standing firm against the wave of issues unraveling other companies in radiation protection gear. They’ve got a...

Continue Reading
Investigation into Potential Violations of Securities Laws

Updated Category News Views 276

Investigation into Potential Violations of Securities Laws Halper Sadeh LLC, a dedicated investor rights law firm, has launched an investigation into several companies regarding potential breaches of fiduciary duties and violations of federal securities laws. This initiative particularly aims to benefit shareholders of Old Point Financial Corporation, ProAssurance...

Continue Reading
Concerns Rise Over Fluoride in Children's Oral Products

Updated Category News Views 150

Lawsuits Target Leading Oral Health Brands Recent legal troubles have emerged for Procter & Gamble and Colgate-Palmolive regarding their children's oral care products. Parents are voicing their concerns through multiple lawsuits against these industry giants, claiming that fluoride in toothpaste and mouth rinses poses health risks for young children. Key Products Under...

Continue Reading